Top Markets
Coin of the day
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Rangering i aksjer #2738
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Aksjekurs
$70.50
Sist synkronisert: 2025-11-14
Markedsverdi
$7.33B
Endring (1 dag)
0.00%
Endring (1 år)
116.32%
Land
US
Handel Metsera, Inc. (MTSR)

Kategori

Historikk for aksjesplitt for Metsera, Inc. (MTSR)
Aksjen Metsera, Inc. (symbol: MTSR) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 25, 2026.
Én MTSR-aksje kjøpt før Aug 25, 2026 tilsvarer i dag 0 MTSR-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH